Key result
Spontaneous echo contrast linked to ~8.3-fold higher thromboembolism in RHD, but attenuated by AF adjustment.
Why the study?
Stroke and thromboembolism occur in rheumatic heart disease beyond documented atrial fibrillation, but the associations of non-AF clinical and echocardiographic predictors are not well synthesized.
Do non-AF clinical and echocardiographic predictors independently predict ischemic stroke and systemic thromboembolism in patients with rheumatic heart disease?
Meta-Analysis (n=8,206)
Do non-AF clinical and echocardiographic predictors independently predict ischemic stroke and systemic thromboembolism in patients with rheumatic heart disease?
In rheumatic heart disease, thromboembolic risk extends beyond atrial fibrillation, with older age, prior thromboembolism, and impaired LA mechanical/reservoir function showing independent predictive value.
Spontaneous echo contrast association with thromboembolism attenuates after AF adjustment in RHD; confirms AF dominance and leaves open independent value of other LA parameters.
Purpose Atrial fibrillation (AF) is the best‐established thromboembolic risk factor in rheumatic heart disease (RHD), but stroke and thromboembolism also occur without documented AF. We systematically synthesised associations between non‐AF clinical/echocardiographic predictors and thromboembolism in RHD, comparing AF‐adjusted with unadjusted estimates. Methods PubMed/MEDLINE, Embase, Scopus, and Web of Science were searched, supplemented by Google Scholar and citation screening. Eligible studies evaluated RHD patients with ≥1 non‐AF predictor of stroke or thromboembolism. Two reviewers performed selection, extraction, and QUIPS risk‐of‐bias assessment; certainty was graded using GRADE. Unadjusted, adjusted, and AF‐adjusted estimates were extracted separately, and random‐effects meta‐analysis was performed when feasible. Results Nineteen studies (∼8,206 patients) met eligibility criteria. SEC, LA size/volume, LA/appendage thrombus, LA appendage flow, LA mechanical function, mitral valve severity, age, and previous thromboembolism were most frequently examined. Four studies provided comparable crude ORs for SEC (pooled OR 8.27, 95% CI 3.21–21.29; I 2 = 66%), substantially attenuated after AF adjustment (as low as OR 1.7, 95% CI 1.1–3.0). Older age and previous stroke remained associated with thromboembolism in AF‐inclusive models, and LA mechanical/reservoir function showed consistent inverse associations, including in sinus rhythm. Certainty was low for SEC, age, and LA function; moderate for previous stroke/thromboembolism; very low for anticoagulation non‐use. Conclusion In RHD, thromboembolic risk extends beyond documented AF. SEC showed the strongest unadjusted association but was substantially attenuated after AF adjustment, likely partly reflecting subclinical AF; it is TEE‐dependent and inconsistently graded. Older age, previous thromboembolism, and impaired LA mechanical/reservoir function showed more persistent associations after AF‐inclusive adjustment; prospective validation is needed.
No takes yet. Share an insight, caveat, or question.
Baby et al. (2026) conducted a meta-analysis in Rheumatic heart disease (n=8,206). Spontaneous echocardiographic contrast (SEC) vs. Patients without SEC was evaluated on Thromboembolism (unadjusted association with SEC) (OR 8.27, 95% CI 3.21-21.29). Spontaneous echocardiographic contrast had the strongest unadjusted association with thromboembolism in RHD (OR 8.27; 95% CI 3.21-21.29), but was substantially attenuated after AF adjustment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: